M-CSF promotes the development of monocytic MDSCs (M-MDSCs) that mainly utilize nitric oxide (derived from iNOS), IL-10, TGF-β, and PD-L1 to suppress anti-tumor immune responses. This evidence concerns the gene NOS2 and neoplasm.